Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI
Abstract Background Although ticagrelor is recommended as opposed to clopidogrel in antiplatelet strategy for patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI), evidence is limited in patients with cardiogenic shock (CS). Ob...
Saved in:
| Main Authors: | Can Zhou, Minghui Zhang, Zixu Zhao, Enze Li, Yichen Zhao, Wei Luo, Keyang Zheng, Yu Liu, Chengqian Yin, Xinyong Zhang, Hai Gao, Dong Zhao, Changsheng Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Thrombosis Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12959-025-00721-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of post-procedure anticoagulation in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary percutaneous coronary intervention
by: Can Zhou, et al.
Published: (2025-03-01) -
Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock
by: Angga Dwi Prasetyo, et al.
Published: (2025-01-01) -
DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock
by: Norman Mangner, et al.
Published: (2025-08-01) -
Risk Factors for Hospital Mortality in Acute ST-Segment Elevation Coronary Syndrome Complicated by Cardiogenic Shock
by: O. V. Arsenicheva
Published: (2021-08-01) -
Complete percutaneous myocardial revascularization in patients with STEMI complicated by cardiogenic shock
by: Petrović Milovan, et al.
Published: (2019-01-01)